How is agonizing leg pain associated with an intrauterine device?
Jäckel, K.; Braschler, T.; Jochum, W.; Hülder, T.; Knechtle, B.
Praxis 104(10): 517-522
2015
ISSN/ISBN: 1661-8157 PMID: 26098054 DOI: 10.1024/1661-8157/a002002Document Number: 638947
We report on a typical clinical course of pelvic actinomycosis: initial uncharacteristic discomfort develops into a systemic illness associated with a pelvic mass, which progresses so fast that along with the systemic infection further symptoms can be reduced to its growth rate--tiredness, abdominal pain, micturition deficiency, and leg pain. Distinction between malignancy and pelvic actinomycosis could be made only intraoperative. After hysterectomy and with antibiotics the patient recovered quickly.
Document emailed within 0-6 h
Related Documents
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972Lopez, L.M.; Bernholc, A.; Zeng, Y.; Allen, R.H.; Bartz, D.; O'Brien, P.A.; Hubacher, D. 2015: Interventions for pain with intrauterine device insertion Cochrane Database of Systematic Reviews 7: Cd007373
Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Ngo, L.L.; Ward, K.K.; Mody, S.K. 2015: Ketorolac for Pain Control with Intrauterine Device Placement: a Randomized Controlled Trial Obstetrics and Gynecology 126(1): 29-36
Cobellis, L.; Razzi, S.; Fava, A.; Severi, F.M.; Igarashi, M.; Petraglia, F. 2004: A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis Fertility and Sterility 82(1): 239-240
Allen, R.H.; Carey, M.S.; Raker, C.; Goyal, V.; Matteson, K. 2014: A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(3): 263-267
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Matorras, R.; Ballesteros, A.; Prieto, B.ña.; Ocerin, I.; Expósito, A.; Pijoan, J.é I.; Crisol, L. 2011: Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis Journal of Reproductive Medicine 56(11-12): 497-503
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
Tornblom-Paulander, S.; Tingåker, B.K.; Werner, A.; Liliecreutz, C.; Conner, P.; Wessel, H.; Ekman-Ordeberg, G. 2015: Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial Fertility and Sterility 103(2): 422-427
Yang, Q.; Tian, X.K.; Chau, X.J. 1991: Relationship between intrauterine device and intrauterine pressure and levels of PGs in uterine fluid Sheng Zhi Yu Bi Yun 11(4): 39-45